152 related articles for article (PubMed ID: 34192476)
21. Syntheses and Evaluation of New Bisacridine Derivatives for Dual Binding of G-Quadruplex and i-Motif in Regulating Oncogene
Kuang G; Zhang M; Kang S; Hu D; Li X; Wei Z; Gong X; An LK; Huang ZS; Shu B; Li D
J Med Chem; 2020 Sep; 63(17):9136-9153. PubMed ID: 32787078
[TBL] [Abstract][Full Text] [Related]
22. NM23-H2 may play an indirect role in transcriptional activation of c-myc gene expression but does not cleave the nuclease hypersensitive element III(1).
Dexheimer TS; Carey SS; Zuohe S; Gokhale VM; Hu X; Murata LB; Maes EM; Weichsel A; Sun D; Meuillet EJ; Montfort WR; Hurley LH
Mol Cancer Ther; 2009 May; 8(5):1363-77. PubMed ID: 19435876
[TBL] [Abstract][Full Text] [Related]
23. Novel interaction of the Z-DNA binding domain of human ADAR1 with the oncogenic c-Myc promoter G-quadruplex.
Kang HJ; Le TV; Kim K; Hur J; Kim KK; Park HJ
J Mol Biol; 2014 Jul; 426(14):2594-604. PubMed ID: 24813121
[TBL] [Abstract][Full Text] [Related]
24. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer.
Chan DS; Yang H; Kwan MH; Cheng Z; Lee P; Bai LP; Jiang ZH; Wong CY; Fong WF; Leung CH; Ma DL
Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506
[TBL] [Abstract][Full Text] [Related]
25. Drug targeting of the c-MYC promoter to repress gene expression via a G-quadruplex silencer element.
Hurley LH; Von Hoff DD; Siddiqui-Jain A; Yang D
Semin Oncol; 2006 Aug; 33(4):498-512. PubMed ID: 16890804
[TBL] [Abstract][Full Text] [Related]
26. Disubstituted 1,8-dipyrazolcarbazole derivatives as a new type of c-myc G-quadruplex binding ligands.
Chen WJ; Zhou CX; Yao PF; Wang XX; Tan JH; Li D; Ou TM; Gu LQ; Huang ZS
Bioorg Med Chem; 2012 May; 20(9):2829-36. PubMed ID: 22484007
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of cell proliferation by quindoline derivative (SYUIQ-05) through its preferential interaction with c-myc promoter G-quadruplex.
Ou TM; Lin J; Lu YJ; Hou JQ; Tan JH; Chen SH; Li Z; Li YP; Li D; Gu LQ; Huang ZS
J Med Chem; 2011 Aug; 54(16):5671-9. PubMed ID: 21774525
[TBL] [Abstract][Full Text] [Related]
28. Exploring the Parallel G-Quadruplex Nucleic Acid World: A Spectroscopic and Computational Investigation on the Binding of the c-myc Oncogene NHE III1 Region by the Phytochemical Polydatin.
Greco F; Musumeci D; Borbone N; Falanga AP; D'Errico S; Terracciano M; Piccialli I; Roviello GN; Oliviero G
Molecules; 2022 May; 27(9):. PubMed ID: 35566347
[TBL] [Abstract][Full Text] [Related]
29. A Comparative Docking Strategy to Identify Polyphenolic Derivatives as Promising Antineoplastic Binders of G-quadruplex DNA c-myc and bcl-2 Sequences.
Costa G; Rocca R; Moraca F; Talarico C; Romeo I; Ortuso F; Alcaro S; Artese A
Mol Inform; 2016 Sep; 35(8-9):391-402. PubMed ID: 27546043
[TBL] [Abstract][Full Text] [Related]
30. Interactions between a Bioflavonoid and c-MYC Promoter G-Quadruplex DNA: Ensemble and Single-Molecule Investigations.
Paul S; Hossain SS; M BD; Samanta A
J Phys Chem B; 2019 Mar; 123(9):2022-2031. PubMed ID: 30758965
[TBL] [Abstract][Full Text] [Related]
31. Solution structure of the biologically relevant G-quadruplex element in the human c-MYC promoter. Implications for G-quadruplex stabilization.
Ambrus A; Chen D; Dai J; Jones RA; Yang D
Biochemistry; 2005 Feb; 44(6):2048-58. PubMed ID: 15697230
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of a flexile G-quadruplex in the distal promoter region of stemness gene REX1.
Roy A; Basu D; Bose D; Dutta A; Dastidar SG; Chatterjee S
Int J Biol Macromol; 2023 Mar; 231():123263. PubMed ID: 36649868
[TBL] [Abstract][Full Text] [Related]
33. c-Myc quadruplex-forming sequence Pu-27 induces extensive damage in both telomeric and nontelomeric regions of DNA.
Islam MA; Thomas SD; Murty VV; Sedoris KJ; Miller DM
J Biol Chem; 2014 Mar; 289(12):8521-31. PubMed ID: 24464582
[TBL] [Abstract][Full Text] [Related]
34. Regulation of the equilibrium between G-quadruplex and duplex DNA in promoter of human c-myc oncogene by a pyrene derivative.
Zhang Z; He X; Yuan G
Int J Biol Macromol; 2011 Dec; 49(5):1173-6. PubMed ID: 21683090
[TBL] [Abstract][Full Text] [Related]
35. Silencing c-MYC expression by targeting quadruplex in P1 promoter using locked nucleic acid trap.
Kumar N; Patowary A; Sivasubbu S; Petersen M; Maiti S
Biochemistry; 2008 Dec; 47(50):13179-88. PubMed ID: 19053274
[TBL] [Abstract][Full Text] [Related]
36. Human MYC G-quadruplex: From discovery to a cancer therapeutic target.
Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579
[TBL] [Abstract][Full Text] [Related]
37. A dihydroindolizino indole derivative selectively stabilizes G-quadruplex DNA and down-regulates c-MYC expression in human cancer cells.
Nagesh N; Raju G; Srinivas R; Ramesh P; Reddy MD; Reddy ChR
Biochim Biophys Acta; 2015 Jan; 1850(1):129-40. PubMed ID: 25452213
[TBL] [Abstract][Full Text] [Related]
38. Resolving the Ligand-Binding Specificity in c-MYC G-Quadruplex DNA: Absolute Binding Free Energy Calculations and SPR Experiment.
Deng N; Wickstrom L; Cieplak P; Lin C; Yang D
J Phys Chem B; 2017 Nov; 121(46):10484-10497. PubMed ID: 29086571
[TBL] [Abstract][Full Text] [Related]
39. Non-fused imidazole-biphenyl analogs repress triple-negative breast cancer growth by mainly stabilizing the c-MYC G-quadruplex via a multi-site binding mode.
Wang XD; Wang JX; Yu BY; Zhang SQ; Hu MH
Bioorg Med Chem; 2023 Jun; 88-89():117336. PubMed ID: 37209638
[TBL] [Abstract][Full Text] [Related]
40. Structure-based design of platinum(II) complexes as c-myc oncogene down-regulators and luminescent probes for G-quadruplex DNA.
Wang P; Leung CH; Ma DL; Yan SC; Che CM
Chemistry; 2010 Jun; 16(23):6900-11. PubMed ID: 20437426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
